Crispr Therapeutics' current revenue from CASGEVY is limited by high costs, profit-sharing, and logistical hurdles. Click ...

In a ground-breaking first for South Africa and the African continent, local patients are participating in a pioneering international gene-editing clinical trial that may revolutionise treatment for ...

In a global first for Africa, UCT is participating in a clinical trial to reprogramme genes and halt hereditary angioedema.

Crispr Therapeutics AG leverages CASGEVY's rollout, a robust pipeline in cardiovascular, oncology, & partnerships to large ...

SNIPR Biome ApS ("SNIPR”), the company pioneering the development of precision medicines using CRISPR technology for microbial gene therapy, today announced that the first patient has been dosed in ...

An international clinical trial led by WashU Medicine researchers shows an innovative CAR-T cell immunotherapy is promising ...

Although our cellular clocks differ dramatically, scientists argue that human aging is one of the highest risk factors for a ...

Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, have found that gene editing using ...

This video explores how CRISPR, the groundbreaking gene-editing technology, is being used in clinical trials to partially restore sight in people with inherited retinal diseases. We break down the ...

Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in ...

GenEditBio has dosed the first subject in an investigator-initiated trial of its in vivo genome editing programme, GEB-101, ...